On the 6th of November, the French company Cellectis saved a 11th’ month’s baby, Layla, suffering from leukemia. The company works on immunotherapy, found an approach to improve the immune system through a treatment consisting of developing immune cells of modified DNA which can detect and destroy tumours. « Her Leukemia was so aggressive that such a response is almost a miracle », said Paul Veys, a professor and director of bone marrow transplant at GOSH who led the team treating Layla at the hospital. Before trying the experimental treatment, the child went through several medical examinations. She underwent chemotherapy and operation of bone marrow which proved unsuccessful. Ashleigh Richards, the father of the young girl shared his painful adventure: “Doctors explained that even if we could try the treatment, there was no guarantee that it would work but we prayed it would”. The medical team on the other hand explained that the experimental treatment was promising but the results weren’t sure: “We have only used this treatment on a little girl before, and we have to be careful before telling that it’s an appropriate treatment for child”.
Anaïs Grès, IEJ3E2
Baby Layla (L) is seen with her parents, Lisa and Ashleigh, and her older sister Reya at Great Ormond Street Hospital (GOSH) in London in this November 4, 2015 handout photo by the hospital released on November 5, 2015. REUTERS/Great Ormond Street Hospital/Handout via Reuters.